Dana P Goldman

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data
    Dana P Goldman
    Medicine and Public Policy, Leonard D Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles
    Health Aff (Millwood) 30:84-90. 2011
  2. ncbi How costly is hospital quality? A revealed-preference approach
    John A Romley
    University of Southern California, Los Angeles, and the RAND Corporation
    J Ind Econ 59:578-608. 2011
  3. ncbi Physician prescribing behavior and its impact on patient-level outcomes
    Geoffrey F Joyce
    Department of Pharmaceutical Economics and Policy, University of Southern California, 3335 S Figueroa, Unit A, Los Angeles, CA 90007, USA
    Am J Manag Care 17:e462-71. 2011
  4. ncbi Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population
    John A Romley
    Leonard D Schaeffer Center for Health Policy and Economics and Price School of Public Policy, University of Southern California, Los Angeles, California 90089, USA
    Diabetes Technol Ther 14:904-11. 2012
  5. ncbi Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs
    John A Romley
    Price School of Public Policy, University of Southern California, Los Angeles, USA
    Health Aff (Millwood) 31:683-90. 2012
  6. ncbi The value of specialty oncology drugs
    Dana P Goldman
    Schaeffer Center for Health Policy and Economics, Schools of Pharmacy and Policy, Planning, and Development, University of Southern California, Ralph and Goldy Lewis Hall 214, Los Angeles, CA 90089 0626, USA
    Health Serv Res 45:115-32. 2010
  7. ncbi Hospital spending and inpatient mortality: evidence from California: an observational study
    John A Romley
    Leonard D Schaeffer Center for Health Policy and Economics, University of Southern California, 650 Childs Way, Los Angeles, CA 90089, USA
    Ann Intern Med 154:160-7. 2011
  8. ncbi Prescription medication abuse and illegitimate internet-based pharmacies
    Anupam B Jena
    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Wang Ambulatory Care Center, Boston, Massachusetts 02114, USA
    Ann Intern Med 155:848-50. 2011

Detail Information

Publications8

  1. ncbi The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data
    Dana P Goldman
    Medicine and Public Policy, Leonard D Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles
    Health Aff (Millwood) 30:84-90. 2011
    ..We conclude that Americans would benefit from a longer period of data exclusivity...
  2. ncbi How costly is hospital quality? A revealed-preference approach
    John A Romley
    University of Southern California, Los Angeles, and the RAND Corporation
    J Ind Econ 59:578-608. 2011
    ..Thus, non-clinical aspects of the hospital experience (perhaps including patient amenities) play important roles in hospital demand, competition, and costs...
  3. ncbi Physician prescribing behavior and its impact on patient-level outcomes
    Geoffrey F Joyce
    Department of Pharmaceutical Economics and Policy, University of Southern California, 3335 S Figueroa, Unit A, Los Angeles, CA 90007, USA
    Am J Manag Care 17:e462-71. 2011
    ..We examine how broadly physicians prescribe within the 10 most prevalent therapeutic classes, the factors affecting their choices, and the impact of their prescribing behavior on patient-level outcomes...
  4. ncbi Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population
    John A Romley
    Leonard D Schaeffer Center for Health Policy and Economics and Price School of Public Policy, University of Southern California, Los Angeles, California 90089, USA
    Diabetes Technol Ther 14:904-11. 2012
    ..Postmarketing reports have linked exenatide use with acute pancreatitis and pancreatic cancer, but a definitive relationship has yet to be established...
  5. ncbi Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs
    John A Romley
    Price School of Public Policy, University of Southern California, Los Angeles, USA
    Health Aff (Millwood) 31:683-90. 2012
    ..Given the value that people assign to generous coverage of specialty drugs, having high cost sharing on these drugs seemingly runs contrary to what people value in their health insurance...
  6. ncbi The value of specialty oncology drugs
    Dana P Goldman
    Schaeffer Center for Health Policy and Economics, Schools of Pharmacy and Policy, Planning, and Development, University of Southern California, Ralph and Goldy Lewis Hall 214, Los Angeles, CA 90089 0626, USA
    Health Serv Res 45:115-32. 2010
    ..To estimate patients' elasticity of demand, willingness to pay, and consumer surplus for five high-cost specialty medications treating metastatic disease or hematologic malignancies...
  7. ncbi Hospital spending and inpatient mortality: evidence from California: an observational study
    John A Romley
    Leonard D Schaeffer Center for Health Policy and Economics, University of Southern California, 650 Childs Way, Los Angeles, CA 90089, USA
    Ann Intern Med 154:160-7. 2011
    ..The relationship between hospital spending and inpatient mortality is less well understood...
  8. ncbi Prescription medication abuse and illegitimate internet-based pharmacies
    Anupam B Jena
    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Wang Ambulatory Care Center, Boston, Massachusetts 02114, USA
    Ann Intern Med 155:848-50. 2011
    ....